An Antigen-Free, Plasmacytoid Dendritic Cell–Targeting Immunotherapy To Bolster Memory CD8+T Cells in Nonhuman Primates-Reference-Cited by-同舟云学术

An Antigen-Free, Plasmacytoid Dendritic Cell–Targeting Immunotherapy To Bolster Memory CD8+T Cells in Nonhuman Primates

Published:2018-02-05 Issue:6 Volume:200 Page:2067-2075
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Masuta Yuji,Yamamoto Takuya^ORCID,Natsume-Kitatani Yayoi,Kanuma Tomohiro^ORCID,Moriishi Eiko,Kobiyama Kouji^ORCID,Mizuguchi Kenji^ORCID,Yasutomi Yasuhiro^ORCID,Ishii Ken J.^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. Dendritic Cells In Vivo: A Key Target for a New Vaccine Science

2. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

3. Modulating vaccine responses with dendritic cells and Toll-like receptors

4. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

5. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates;Molecular Therapy - Methods & Clinical Development;2023-03

2. CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study;BMC Cancer;2022-07-07

3. In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy;Scientific Reports;2022-02-08

4. Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade;Frontiers in Immunology;2020-09-25

5. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon;Tuberculosis;2020-07